Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,407,518
-
Share change
-
-18,831,784
-
Total reported value
-
$7,135,000
-
Price per share
-
$1.32
-
Number of holders
-
6
-
Value change
-
-$25,420,780
-
Number of sells
-
41
Institutional Holders of ODONATE THERAPEUTICS INC - COM (ODTC) as of Q1 2022
As of 31 Mar 2022,
ODONATE THERAPEUTICS INC - COM (ODTC) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,407,518 shares.
The largest 6 holders included
BOXER CAPITAL, LLC, Samsara BioCapital, LLC, ACADIAN ASSET MANAGEMENT LLC, Hennion & Walsh Asset Management, Inc., Tower Research Capital LLC (TRC), and SIMPLEX TRADING, LLC.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.